| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $969.2M | — | -7.2% |
| Cost of Revenue | $643.7M | — | -1.2% |
| Gross Profit | $325.5M | — | -17.0% |
| R&D Expense | $24.6M | — | -7.9% |
| SG&A Expense | $115.0M | — | +2.5% |
| Operating Income | -$372.3M | — | -893.8% |
| Pre-tax Income | -$408.5M | — | -5021.7% |
| Income Tax | -$18.7M | — | -328.0% |
| Net Income | -$398.6M | — | -6128.1% |
| EPS (Basic) | -$2.87 | — | -5640.0% |
| EPS (Diluted) | -$2.87 | — | -5640.0% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $697.1M | +13.8% | -2.7% |
| Inventory | $1.12B | -2.4% | -2.9% |
| Current Assets | $2.71B | -3.0% | +7.1% |
| Total Assets | $7.98B | -6.5% | -18.2% |
| Current Liabilities | $997.6M | -1.5% | -7.1% |
| Long-term Debt | $3.62B | +0.5% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$113.6M | — | -76.1% |
| Capital Expenditures | $13.8M | — | -45.9% |
| Investing Cash Flow | -$12.4M | — | +51.8% |
| Financing Cash Flow | -$45.3M | — | +26.7% |
| Free Cash Flow | -$127.4M | — | -41.6% |
| +0.8% |
| Total Liabilities | $5.48B | -2.1% | +1.6% |
| Stockholders' Equity | $2.50B | -14.9% | -42.7% |